Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells

Clinical and Experimental Metastasis

Volumn 22, Issue 3, 2005, Pages 255-263

  Manni, Andrea ^a   Washington, Sharlene ^a   Hu, Xin ^a   Griffith, James W ^a   Bruggeman, Richard ^a   Demers, Laurence M ^a   Mauger, David ^a   Verderame, Michael F ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer metastasis; DFMO; Polyamines; SAM486A

Indexed keywords

ADENOSYLMETHIONINE DECARBOXYLASE; EFLORNITHINE; ENZYME INHIBITOR; POLYAMINE; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INVASION; DRUG EFFECT; HUMAN; HUMAN CELL; LUNG METASTASIS; METASTASIS; PHOSPHORYLATION; POLYAMINE SYNTHESIS; TUMOR GROWTH;

AMIDINES; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; EFLORNITHINE; FEMALE; HUMANS; INDANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; POLYAMINES; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR;

EID: 24744437496     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-005-8480-1     Document Type: Article

References (27)

1. HG Thompson LD Meeker EJ Herbst AM Ronan R Minocha 1985 Effect of concentration of D, 1-2-difluoromethylornithine on murine mammary carcinogenesis Cancer Res 45 1170 73
2. HJ Thompson AM Roman KA Rotacco LD Meeker 1986 Effect of Tamoxifen and D, 1-2-difluromethylornithine on the growth, ornithine decarboxylase activity, and polyamine content of mammary carcinomas induced by 1-methyl-1-nitrosurea Carcinogenesis 7 837 40
3. 1- acetylspermidine in human breast cancer Cancer Lett 45 83 6
4. A Manni R Grove S Kunselman L Demers 1995 Involvement of the polyamine pathway in breast cancer progression Cancer Lett 92 49 57
5. A Manni D Mauger P Gimotty B Badger 1996 Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer Clin Cancer Res 2 1901 5
6. F Canizares J Salinias M de las Heras J Diaz I Tovar P Martinez R Penafiel 1999 Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters Clin Cancer Res 5 2035 41
7. A Manni S Washington JW Griffith MF Verderame D Mauger LM Demers RS Samant DR Welch 2002 Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells Clin Exptl Mets 19 95 105
8. A Manni S Washington L Craig M Cloud JW Griffith MF Verderame LJ Texter D Mauger LM Demers JF Harms DR Welch 2003 Effects of α- difluoromethylornitine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice Clin Exptl Mets 20 321 5
9. U Regenass H Mett J Stanek M Muller D Kramer CW Porter 1994 CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity Cancer Res 54 3210 3217
10. A Manni B Badger R Wechter S Kunselman A Rossini L Demers 1995 Biochemical and growth-modulatory effects of the new S-adenosylmethionine decarboxylase inhibitor GCP 48664 in malignant and immortalized normal human breast epithelial cells in culture Int J Cancer 62 485 91
11. LI Siu ER Rowinsky LA Hammond GR Weiss M Hidalgo GM Clark J Moczygemba L Choi R Linnartz NC Barbet IT Sklenar R Capdeville G Gan CW Porter DD Von Hoff SG Eckhardt 2002 A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with advanced solid malignancies Clin Cancer Res 8 2156 66
12. X Hu S Washington MF Verderame LM Demers D Mauger A Manni 2004 Biological activity of the S-adenosylmethionine decarboxylase (SAMDC) inhibitor SAM486A in human breast cancer cells in vitro and in vivo Int J Oncol 25 1831 8
13. A Manni S Fischer M Franks S Washington R DeArment J Griffith L Demers M Verderame B Leiby D Mauger 2002 S-adenosylmethionine decarboxylase (SAMDC) overexpression reduces invasiveness and tumorigenicity in nude mice of MCF-7 breast cancer cells Int J Oncol 19 317 23
14. A Manni SH Astrow S Gammon J Thompson D Mauger S Washington 2001 Immunohistochemical detection of ornithine-decarboxylase in primary and metastatic human breast cancer specimens Breast Cancer Res Treat 67 147 56
15. A Manni S Washington D Mauger DA Hackett MF Verderame 2004 Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor α-difluoromethylornithine (DFMO) in human breast cancer cells Clin Experim Metastasis 21 461 7
16. K Maeda Y Nishiguchi SM Kang M Yashiro N Onoda T Sawada T Ishikawa K Hirakawa 2001 Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer Oncol Rep 8 763 6
17. V Zabrenetzky CC Harris PS Steeg DD Roberts 1994 Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines Int J Cancer 59 191 5
18. DL Weinstat-Saslow VS Zabrenetzky K VanHoutte WA Frazier DD Roberts PS Steeg 1994 Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis Cancer Res 54 6504 11
19. GN Hortobagyi 2001 Adjuvant systemic therapy for early breast cancer: progress and controversies Clinical Cancer Res 7 1839 42
20. S Kamada U Kikkawa Y Tsujimoto T Hunter 2005 Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein(s) J Biol Chem 280 857 60
21. RM Ray BJ Zimmerman SA McCormack TB Patel LR Johnson 1999 Polyamine depletion arrests cell cycle and induces inhibitors p21(Waf1/Cip1), p27(Kip1), and p53 in IEC-6 cells Am J Physiol 276 C684 91
22. Y Chen K Alm S Vujcic DL Kramer K Kee P Diegelman CW Porter 2003 The role of mitogen-activated protein kinase activation in determining cellular outcomes in polyamine analogue-treated human melanoma cells Cancer Res 63 3619 25
23. A Manni R Wechter MF Verderame D Mauger 1998 Cooperativity between the polyamine pathway and HER-2neu in transformation of human mammary epithelial cells in culture: role of the MAPK pathway Int J Cancer 76 563 70
24. S Kubota H Kiyosawa Y Nomura T Yamada Y Seyama 1997 Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: cellular transformation and invasion J Nat Cancer Inst 89 567 71
25. KE Bornfeldt JS Campbell H Koyama GM Argast CL Leslie EW Raines 1997 The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets J Clin Invest 100 875 885
26. KM Pumiglia SJ Decker 1997 Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway Proc Natl Acad Sci USA 94 448 452
27. H Schramek E Feifel E Healy V Pollack 1997 Constitutively active mutant of mitogen-activated protein kinase kinase MEK1 induces epithelial differentiation and growth inhibition in Madin-Darby canine kidney-C7 cells J Biol Chem 272 11426 33